When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOV - Myovant: Poised To Overcome Regulatory Issues
Myovant Sciences Ltd.
The steep decline in Myovant Sciences share price is due to an FDA notice regarding relugolix label expansion for endometriosis.
Irrespective of the FDA decision, I strongly believe that relugolix will ultimately gain approval for endometriosis (perhaps in either Q3 or Q4 this year).
Already marketed for two indications (i.e., advanced prostate cancer and uterine fibroids), you can expect relugolix sales to ramp up steadily and surely toward the blockbuster range.